Apogee Therapeutics, Inc. Common Stock (APGE) — Defensive Interval Ratio
Apogee Therapeutics, Inc. Common Stock (APGE) has a Defensive Interval Ratio of 6736 days as of March 2026. Defensive assets of $608.09 Million (cash $-, short-term investments $608.09 Million, receivables $-) cover 6736 days of daily cash needs of $90.28K/day. See APGE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Apogee Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Apogee Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 6736 days, meaning defensive assets of $608.09 Million can fund 6736 days of operations without new revenue. See Apogee Therapeutics, Inc. Common Stock balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Apogee Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Apogee Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Apogee Therapeutics, Inc. Common Stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 7830 days | $598.64 Million | $76.45K/day | $- | $598.64 Million | ▲ +2928 days |
| 2024 | 4902 days | $383.56 Million | $78.25K/day | $- | $378.86 Million | ▼ -40 days |
| 2023 | 4942 days | $278.36 Million | $56.32K/day | $- | $277.14 Million | ▲ +4942 days |
| 2022 | 0 days | $0.00 | $27.34K/day | $- | $0.00 | — |